New Key Statistics Module, Z-Score and F-Score
OTCPK:NEGXF Key Ratios
| Market Cap $ M | 13.33 |
| Enterprise Value $ M | 13.57 |
| P/E(ttm) | 9,999.00 |
| PE Ratio without NRI | 9,999.00 |
| Forward PE Ratio | -- |
| Price/Book | 2.90 |
| Price/Sales | 1.16 |
| Price/Free Cash Flow | 12.75 |
| Price/Owner Earnings | 21.25 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 11.00 |
| EPS (TTM) $ | -- |
| Beneish M-Score | -2.53 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | 5.60 |
| EV-to-EBIT | 278.98 |
| EV-to-EBITDA | 13.66 |
| PEG | -- |
| Shares Outstanding M | 70.92 |
| Net Margin (%) | 0.56 |
| Operating Margin % | 1.30 |
| Pre-tax Margin (%) | 0.01 |
| Quick Ratio | 1.08 |
| Current Ratio | 1.08 |
| ROA % (ttm) | 0.29 |
| ROE % (ttm) | 1.05 |
| ROIC % (ttm) | -19.10 |
| Dividend Yield % | 3.91 |
| Altman Z-Score | 0.96 |
NEGXF Number of Guru Trades
NEGXF Volume of Guru Trades
Gurus Latest Trades with OTCPK:NEGXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:NEGXF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NexgenRx Inc Insider Transactions
No Available Data
News about OTCPK:NEGXF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers